Skip to main content
logo
Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
23.50
0.00 (0.00%)
Jul 19, 2026, 3:10 PM AST

TADAWUL:9620 Financials Overview

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
20.3820.3819.8618.0317.01
Revenue Growth
1.54%2.62%10.11%6.04%-
Gross Profit
7.797.798.298.178.31
Operating Income
2.52.55.124.343.73
Net Income
1.971.974.784.163.51
Earnings Per Share
0.790.791.912.82-
EPS Growth
-61.54%-58.84%-32.21%--

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Maintenance and Operations
0.230.23---
Medical Services
16.116.116.9316.0416.37
Medical Supplies
4.054.052.9220.63
Total
20.3820.3819.8618.0317.01

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
10.8410.8418.243.685.74
Total Debt
1.511.511.81.932.62
Net Cash (Debt)
9.339.3316.441.753.11
Net Cash Growth
-43.11%-43.24%838.03%-43.71%-
Net Cash Per Share
3.733.736.581.19-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-2.94-2.945.485.414.72
Capital Expenditures
-4.15-4.15-0.21-7.15-0.19
Free Cash Flow
-7.1-7.15.27-1.744.53
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
38.24%38.24%41.76%45.29%48.87%
Operating Margin
12.28%12.28%25.77%24.09%21.95%
Pretax Margin
12.08%12.08%25.40%23.62%21.37%
Profit Margin
9.65%9.65%24.07%23.08%20.66%
FCF Margin
-34.82%-34.82%26.55%-9.65%26.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
29.8634.6419.35--
P/FCF Ratio
--17.55--
PS Ratio
2.883.354.66--